Skip to main content

Table 2 Comparison of the levels of galectin-3, RDW, Hepc, HS and ferritin before and after treatment between the two groups

From: Correlation between galectin-3, RDW, Hepc, HS and ferritin and prognosis of patients with acute onset of chronic heart failure

Variables

Time

The effective group (n = 66)

The non-effective group (n = 26)

t

P

Galectin-3 (n)

Before treatment

25.39 ± 3.21

31.29 ± 3.12

− 8.000

< 0.001

After treatment

15.27 ± 3.03

19.27 ± 3.09

− 5.670

< 0.001

RDW (fL)

Before treatment

45.39 ± 3.21

48.48 ± 3.09

− 4.200

< 0.001

After treatment

41.28 ± 3.12

44.73 ± 3.02

− 4.818

< 0.001

Hepc (ng/mL)

Before treatment

93.02 ± 9.87

102.98 ± 9.12

− 4.449

< 0.001

After treatment

57.27 ± 9.12

66.35 ± 9.01

− 4.314

< 0.001

HS (μg/L)

Before treatment

191.98 ± 8.32

199.39 ± 8.28

− 3.852

< 0.001

After treatment

179.28 ± 7.66

185.31 ± 7.83

− 3.379

0.001

Ferritin (ng/mL)

Before treatment

28.93 ± 12.12

23.02 ± 11.87

2.118

0.037

After treatment

117.98 ± 13.02

109.98 ± 12.98

2.656

0.009